Trinity Biotech ADR buy StockNews.com
Start price
04.02.24
/
50%
€0.61
Target price
04.02.25
-
Performance (%)
-32.46%
End price
05.02.25
-
Summary
This prediction is currently being closed. The BUY prediction by StockNews_com for Trinity Biotech ADR is performing very badly with a performance of -32.46%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Trinity Biotech ADR | - | - | - |
| iShares Core DAX® | 3.901% | 2.667% | 5.690% |
| iShares Nasdaq 100 | -2.603% | -7.934% | 19.505% |
| iShares Nikkei 225® | -0.545% | -9.754% | 46.053% |
| iShares S&P 500 | -0.881% | -1.488% | 16.911% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten